Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.

被引：0

作者：

Marcucci, G

Caligiuri, MA

Oberkircher, AR

Bloomfield, CD

机构：

[1] OHIO STATE UNIV,DIV HEMATOL ONCOL,COLUMBUS,OH 43210

[2] OHIO STATE UNIV,ARTHUR G JAMES CANC HOSP,DIV HUMAN CANC GENET,COLUMBUS,OH 43210

[3] OHIO STATE UNIV,RES INST,COLUMBUS,OH 43210

来源：

BLOOD | 1997年 / 90卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：270 / 270

页数：1

共 50 条

[31] PCR and RT-PCR based minimal residual disease (MRD) detection in long term follow up childhood acute lymphobalstic leukemia(ALL). [J].

Gameiro, P ;

Papaioannou, M ;

Moreira, I ;

Yetgin, S ;

Potter, MN ;

Prentice, HG ;

Mehta, AB ;

Hoffbrand, AV ;

Foroni, L .

BLOOD, 2001, 98 (11) :318A-318A

[32] POLYMERASE CHAIN-REACTION (PCR) APPROACH FOR THE EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA [J].

BIONDI, A ;

RAMBALDI, A .

STEM CELLS, 1994, 12 (04) :394-401

[33] Use of the reverse transcription polymerase chain reaction (RT-PCR) for the rapid diagnosis of foot and mouth disease in South America [J].

Clavijo, A ;

Viera-Pereira, PJ ;

Bergmann, I .

VETERINARY RESEARCH COMMUNICATIONS, 2003, 27 (01) :63-71

[34] Use of the Reverse Transcription Polymerase Chain Reaction (RT-PCR) for the Rapid Diagnosis of Foot and Mouth Disease in South America [J].

A. Clavijo ;

P.J. Viera-Pereira ;

I. Bergmann .

Veterinary Research Communications, 2003, 27 :63-71

[35] Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay [J].

G Marcucci ;

KJ Livak ;

W Bi ;

MP Strout ;

CD Bloomfield ;

MA Caligiuri .

Leukemia, 1998, 12 :1482-1489

[36] Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay [J].

Marcucci, G ;

Livak, KJ ;

Bi, W ;

Strout, MP ;

Bloomfield, CD ;

Caligiuri, MA .

LEUKEMIA, 1998, 12 (09) :1482-1489

[37] Minimal residual disease (MRD) monitoring with qualitative RT-PCR in chronic myeloid leukemia (CML) patients submitted to allogeneic stem cell transplantation [J].

Bernasconi, P ;

Alessandrino, EP ;

Calatroni, S ;

Caldera, D ;

Colombo, AA ;

Malcovati, L ;

Varettoni, M ;

Cavigliano, PM ;

Rocca, B ;

Boni, M ;

Giardini, I ;

Caresana, M ;

Lazzarino, M .

BONE MARROW TRANSPLANTATION, 2002, 29 :S123-S123

[38] Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia:: A multicenter study of 51 patients [J].

Morschhauser, F ;

Cayuela, JM ;

Martini, S ;

Baruchel, A ;

Rousselot, P ;

Socié, G ;

Berthou, P ;

Jouet, JP ;

Straetmans, N ;

Sigaux, F ;

Fenaux, P ;

Preudhomme, C .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :788-794

[39] Feasibility and clinical significance of real time quantitative reverse transcription polymerase chain reaction (RT-PCR) assay in the study of PML-RARα fusion transcript in patients with acute promyelocytic leukemia. [J].

Gu, BW ;

Hu, J ;

Xu, L ;

Yan, H ;

Jin, WR ;

Zhu, YM ;

Zhao, WL ;

Niu, C ;

Cao, Q ;

Su, XY ;

Ying, HY ;

Chen, Y ;

Xiong, SM ;

Shen, ZX ;

Chen, Z ;

Chen, SJ .

BLOOD, 2000, 96 (11) :313A-313A

[40] Predicting outcome of chronic myelogenous leukemia (CML) post allogeneic marrow transplantation by reverse transcription polymerase chain reaction (RT-PCR). [J].

Khouri, I ;

Champlin, R ;

Przepiorka, D ;

Giralt, S ;

Thall, P ;

Kantarjian, H ;

Cheng, SC ;

Mirza, NQ ;

Deisseroth, AB ;

Lee, MS .

BLOOD, 1996, 88 (10) :3802-3802

← 1 2 3 4 5 →